Revelation Biosciences (REVBW) Short Interest Ratio & Short Volume → AI finds its first serious application (From Wall Street Star) (Ad) Free REVBW Stock Alerts $0.01 0.00 (0.00%) (As of 04/25/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsFinancialsSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsFinancialsSEC FilingsShort InterestSocial Media Revelation Biosciences Short Interest DataCurrent Short Volume1,300 sharesPrevious Short Volume1,700 sharesChange Vs. Previous Month-23.53%Dollar Volume Sold Short$23.01Short Interest Ratio / Days to Cover0.0Last Record DateApril 15, 2024Today's Trading Volume2,975 sharesAverage Trading Volume76,314 sharesToday's Volume Vs. Average4% Short Selling Revelation Biosciences ? Sign up to receive the latest short interest report for Revelation Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatREVBW Short Interest Over TimeREVBW Days to Cover Over TimeREVBW Percentage of Float Shorted Over Time Ad Banyan Hill PublishingThe Best AI Stock to Own in the World Today is Trading for Just $25“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him Revelation Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20241,300 shares $23.01 -23.5%N/A0 $0.02 3/31/20241,700 shares $45.05 -72.6%N/A0 $0.03 3/15/20246,200 shares $128.02 -33.3%N/A0.1 $0.02 2/29/20249,300 shares $204.60 +244.4%N/A0.1 $0.02 2/15/20242,700 shares $21.60 -83.7%N/A0.1 $0.01 1/31/202416,600 shares $124.50 No ChangeN/A0.3 $0.01 8/31/202327,700 shares $498.60 +214.8%N/A0.5 $0.02 8/15/20238,800 shares $155.76 No ChangeN/A0.4 $0.02 7/31/20238,800 shares $132.00 -18.5%N/A0.4 $0.02 7/15/202310,800 shares $194.40 -23.4%N/A0.3 $0.02 6/30/202314,100 shares $250.98 +20.5%N/A0.3 $0.02 6/15/202311,700 shares $232.83 -52.8%N/A0.2 $0.02 5/31/202324,800 shares $488.56 -54.6%N/A0.4 $0.02 5/15/202354,600 shares $829.92 No ChangeN/A0.7 $0.02 9/30/202213,000 shares $546.00 No ChangeN/A0.1 $0.04 9/15/202213,000 shares $804.70 +4.8%N/A0.1 $0.06 8/31/202212,400 shares $629.92 No ChangeN/A0.1 $0.05 REVBW Short Interest - Frequently Asked Questions What is Revelation Biosciences' current short interest? Short interest is the volume of Revelation Biosciences shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 1,300 shares of REVBW short. Learn More on Revelation Biosciences' current short interest. Is Revelation Biosciences' short interest increasing or decreasing? Revelation Biosciences saw a decline in short interest in April. As of April 15th, there was short interest totaling 1,300 shares, a decline of 23.5% from the previous total of 1,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Revelation Biosciences stock? Short selling REVBW is an investing strategy that aims to generate trading profit from Revelation Biosciences as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Revelation Biosciences? A short squeeze for Revelation Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of REVBW, which in turn drives the price of the stock up even further. How often is Revelation Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including REVBW, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: 180 Life Sciences Short Interest Alpha Tau Medical Short Interest Apollomics Short Interest Artelo Biosciences Short Interest BriaCell Therapeutics Short Interest Cardio Diagnostics Short Interest Carmell Short Interest Cassava Sciences Short Interest Celularity Short Interest Clene Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:REVBW) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsJim Cramer’s “The Biggest Drug Ever”Behind the MarketsThe AI stock to buy right nowStockEarningsThe only accurate crypto trading system I know …Weiss RatingsFed launches fourth dollar overhaulStansberry Research